446 related articles for article (PubMed ID: 26747249)
21. A Rare Case of Early T-Precursor Lymphoblastic Lymphoma (ETP-LBL) in a Child With Nijmegen Breakage Syndrome.
R Brannock K; Kahwash SB
Pediatr Dev Pathol; 2024 May; ():10935266241255277. PubMed ID: 38794943
[TBL] [Abstract][Full Text] [Related]
22. Childhood Early T Cell Precursor Acute Lymphoblastic Leukaemia with t(12;17) (p13;q21) Translocation - A Rare Entity or Part of ETP/Myeloid Mixed Phenotype Acute Leukaemia.
Krishnan Y; S G; Joy A; S SP; S RJ; S S
Gulf J Oncolog; 2022 Sep; 1(40):78-82. PubMed ID: 36448075
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
Khurana S; Heckman MG; Craig FE; Cochuyt JJ; Greipp P; Rahman ZA; Sproat LZ; Litzow M; Foran JM; Jiang LJ
Arch Pathol Lab Med; 2024 Apr; 148(4):471-475. PubMed ID: 37522711
[TBL] [Abstract][Full Text] [Related]
24. Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.
La Starza R; Barba G; Demeyer S; Pierini V; Di Giacomo D; Gianfelici V; Schwab C; Matteucci C; Vicente C; Cools J; Messina M; Crescenzi B; Chiaretti S; Foà R; Basso G; Harrison CJ; Mecucci C
Haematologica; 2016 Aug; 101(8):951-8. PubMed ID: 27151989
[TBL] [Abstract][Full Text] [Related]
25. Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study.
Shi H; Yang F; Cao M; Xu T; Zheng P; Guo Y; Su G; Feng S; Li R; Liu R; Liu H; Ma L; Ke X; Hu K
Ann Hematol; 2024 Apr; ():. PubMed ID: 38662205
[TBL] [Abstract][Full Text] [Related]
26. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
[TBL] [Abstract][Full Text] [Related]
27. Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia.
Shimony S; DeAngelo DJ; Luskin MR
Blood Adv; 2024 Jan; 8(1):23-36. PubMed ID: 37389830
[TBL] [Abstract][Full Text] [Related]
28. Absence of terminal deoxynucleotidyl transferase expression in T-ALL/LBL accumulates chromosomal abnormalities to induce drug resistance.
Xiao H; Wang S; Tang Y; Li S; Jiang Y; Yang Y; Zhang Y; Han Y; Wu X; Zheng L; Li Y; Gao Y
Int J Cancer; 2023 Jun; 152(11):2383-2395. PubMed ID: 36757202
[TBL] [Abstract][Full Text] [Related]
29. Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia.
Shimony S; Liu Y; Valtis YK; Paolino JD; Place AE; Brunner AM; Weeks LD; Silverman LB; Vrooman LM; Neuberg DS; Stone RM; DeAngelo DJ; Luskin MR
Blood Adv; 2023 Apr; 7(7):1092-1102. PubMed ID: 36508268
[TBL] [Abstract][Full Text] [Related]
30. Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group.
Smock KJ; Nelson M; Tripp SR; Sanger WG; Abromowitch M; Cairo MS; Perkins SL;
Pediatr Blood Cancer; 2008 Oct; 51(4):489-94. PubMed ID: 18618503
[TBL] [Abstract][Full Text] [Related]
31. Genomic signatures and prognosis of advanced stage Chinese pediatric T cell lymphoblastic lymphoma by whole exome sequencing.
Liu Q; Yu X; Wen J; Yin N; Liao X; Zou P; Guo Y; Song L; Xiao J
Front Pediatr; 2023; 11():1224966. PubMed ID: 37664545
[TBL] [Abstract][Full Text] [Related]
32. [Chinese expert consensus on diagnosis and treatment of adult early T cell precursor acute lymphoblastic leukemia (2023)].
; ;
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):977-982. PubMed ID: 38503519
[No Abstract] [Full Text] [Related]
33. Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine.
Leoncin M; La Starza R; Roti G; Pagliaro L; Bassan R; Mecucci C
Curr Opin Oncol; 2022 Nov; 34(6):738-747. PubMed ID: 36017547
[TBL] [Abstract][Full Text] [Related]
34. Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.
Paolino J; Dimitrov B; Apsel Winger B; Sandoval-Perez A; Rangarajan AV; Ocasio-Martinez N; Tsai HK; Li Y; Robichaud AL; Khalid D; Hatton C; Gillani R; Polonen P; Dilig A; Gotti G; Kavanagh J; Adhav AA; Gow S; Tsai J; Li Y; Ebert BL; Van Allen EM; Bledsoe J; Kim AS; Tasian SK; Cooper SL; Cooper TM; Hijiya N; Sulis ML; Shukla NN; Magee JA; Mullighan CG; Burke MJ; Luskin MR; Mar BG; Jacobson MP; Harris MH; Stegmaier K; Place AE; Pikman Y
Clin Cancer Res; 2023 Nov; 29(22):4613-4626. PubMed ID: 37725576
[TBL] [Abstract][Full Text] [Related]
35. Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia.
Hanbali A; Kotb A; Fakih RE; Alfraih F; Shihata N; Rasheed W; Ahmed SO; Shaheen M; Alhayli S; Alahmari A; Alotaibi A; Alshaibani A; Albabtain A; Alfayez M; Hassan M; Alsharif F; Chaudhri N; Almohareb F; Alzahrani H; Aljurf M
Int J Hematol Oncol; 2023 Feb; 12(1):IJH42. PubMed ID: 36874377
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia.
Mroczek A; Zawitkowska J; Kowalczyk J; Lejman M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467425
[TBL] [Abstract][Full Text] [Related]
37. Chromothripsis is a frequent event and underlies typical genetic changes in early T-cell precursor lymphoblastic leukemia in adults.
Arniani S; Pierini V; Pellanera F; Matteucci C; Di Giacomo D; Bardelli V; Quintini M; Mavridou E; Lema Fernandez AG; Nardelli C; Moretti M; Gorello P; Crescenzi B; Romoli S; Beacci D; Cerrano M; Fracchiolla N; Sica S; Forghieri F; Giglio F; Dargenio M; Elia L; La Starza R; Mecucci C
Leukemia; 2022 Nov; 36(11):2577-2585. PubMed ID: 35974102
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia.
Summers RJ; Jain J; Vasileiadi E; Smith B; Chimenti ML; Yeung TY; Kelvin J; Wang X; Frye SV; Earp HS; Tyner JW; Dreaden EC; DeRyckere D; Graham DK
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551626
[TBL] [Abstract][Full Text] [Related]
39. JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.
Benyoucef A; Haigh K; Cuddihy A; Haigh JJ
Leukemia; 2022 Dec; 36(12):2802-2816. PubMed ID: 36229595
[TBL] [Abstract][Full Text] [Related]
40. TNFAIP3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia.
Chen C; Zhou L; Zhu L; Luo G; Wang L; Zeng C; Zhou H; Li Y
Cancer Med; 2023 Feb; 12(4):3952-3961. PubMed ID: 36056685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
